
Voices in Pharmacy: April 2024 Expert Interviews
Check out these featured Drug Topics expert interviews from April 2024.
At the American Associated Pharmacies (AAP) Annual Conference, Drug Topics sat down with Douglas Hoey, CEO of NCPA, to discuss how the DIR hangover has affected independent pharmacies in 2024, and what both congress and CMS can do to help mitigate its impact.
In a conversation with Drug Topics, Kirollos Hanna, PharmD, director of pharmacy at Minnesota Oncology, addressed trends associated with the integration of new therapies in treatment lines of patients with relapsed or refractory myeloma, as well as what the future may look like for the use of bispecifics in this space.
Kathy Campbell, PharmD, pharmacist and patient advocate at Medicap Pharmacy in Owassa, Oklahoma, and CEO of DrKathy Health, discusses why she believes wellness and proactive health are the future of pharmacy, and the unique value that a wellness-focused pharmacy offers compared to traditional models.
Karen Fancher, PharmD, sat down with Drug Topics to address how hearing the perspectives of colleagues can offer invaluable support to shape individualized approaches to ethical dilemmas in oncology pharmacy.
Drug Topics talked with Eric Fromhart, co-founder and chief growth officer at Aventi Health, about the 340B drug pricing program, pharmacy’s current perspective on it, and why it is important for pharmacies to pursue 340B opportunities.
Scott Soefje, PharmD, discusses how cost structures, reimbursement models, and payer-mandated limitations affect financial decision-making across inpatient care, hospital-based infusion centers, physician-based infusion centers, and home care settings.
Joe McKamey, general manager at Marcrom’s Pharmacy in Manchester, Tennessee, explains why pharmacies should open their own Medicare-focused insurance agency and what steps and preparations they can take to ensure a successful launch and operation.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.